Astrana Health (ASTH) Stock Analysis & Winston Score
Astrana Health is a healthcare company that manages a network of doctors and medical clinics, mostly serving patients in California and other western U.S. states. It focuses on value-based care, meaning it takes responsibility for keeping patients healthy rather than just treating them when they get sick. Its main customers are health insurance plans, including Medicare Advantage and Medicaid programs, which pay Astrana to coordinate care for their members. Astrana makes money primarily through capitation payments — fixed monthly fees per patient from insurance plans — rather than charging for each individual visit. This model can be profitable if patients stay healthy, but thin margins (around 9% gross margin) show how much of that revenue goes to paying the actual doctors and clinics. The company has been growing by acquiring physician groups and expanding into new states, but integrating those acquisitions while managing costs remains its biggest ongoing challenge.
Winston Score: 44/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Weak (5/30)
- Growth: Good (12/20)
- Cash Flow: Strong (7/10)
- Stability: Mixed (3/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: $39.35
Market Cap: $2.0B
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: NASDAQ


